The ACTG1 gene gives cells instructions for a form of actin, a protein that helps them keep their shape and move in a controlled way. If this gene does not work properly, some cells, especially the delicate hair cells in the inner ear, may not function as they should, which can lead to hearing loss. Certain variants in the ACTG1 gene are also linked to a developmental condition called Baraitser-Winter syndrome in some people. ACTG1 is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, which are the working parts of cells. Other genes mainly help determine when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
ACTG1Gene function
What if the gene works
The ACTG1 gene gives cells instructions to make a protein called gamma actin, which helps form the cell's inner support framework. This helps cells keep their shape, move, and support structures in the inner ear needed for hearing.
Risk
What if the gene does not work
Variants in the ACTG1 gene can lead to hearing loss or, in more severe cases, a developmental condition affecting facial features, eye movements, and brain development. Milder and more severe variants can influence when symptoms begin and which features appear.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the ACTG1 gene, no ACTG1-specific treatment or drug choice is currently established.
Conditions associated with ACTG1
Gene function
What if the gene works
Inside many cells, the ACTG1 gene supports the flexible framework that helps them keep their shape and move when needed. Its protein is used every day as cells attach, shift position, and divide. Understanding ACTG1 gene function helps explain how tissues stay organized during normal growth and repair.
The ACTG1 gene helps build thin protein strands that form part of a cell’s inner framework. These strands give cells support while still allowing them to bend and adjust their shape.
Cells use the ACTG1 gene to make controlled shape changes that let them move across surfaces. This supports routine processes such as wound healing, tissue maintenance, and early development.
ACTG1 helps strengthen the areas where a cell anchors to its surroundings and connects with nearby cells. This steady support helps tissues keep their structure during everyday wear and repair.
During cell division, ACTG1 helps form the tightening band that separates one cell into two. This allows the final split to happen in an orderly, coordinated way.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help account for normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most variants in the ACTG1 gene are missense changes that alter the actin protein’s shape or how it joins long filaments, which is central to how ACTG1 gene variants affect cells. Milder variants may only partly disturb filament building or binding to partner proteins, while more severe variants can more strongly disrupt cell structure and movement. This functional range is linked to isolated hearing loss in some people and to earlier, broader developmental features in others.
How variants are linked to conditions
Pathogenic variants in the ACTG1 gene are linked most strongly to inherited hearing loss, especially a form that often starts after speech develops and may worsen over time. Research on how ACTG1 gene variants are linked to hearing loss also identifies Baraitser-Winter syndrome, a condition that can affect facial features, brain development, the eyes, and hearing. In these settings, a disease-causing ACTG1 variant can confirm the genetic diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply contribute to natural differences among people. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the ACTG1 gene itself. In families with an ACTG1 variant, the main driver of risk is usually the variant, while symptoms can still vary from one person to another.
Inheritance of ACTG1 variants
ACTG1-related conditions are usually inherited in an autosomal dominant pattern, which is the key point in understanding how ACTG1 gene variants are inherited. This means a person with a disease-causing variant in one copy of the ACTG1 gene can pass it to each child with a 50% chance. Some ACTG1-related conditions, especially those linked to developmental features present from birth, can also result from a new (de novo) variant that was not inherited from either parent. In families with ACTG1-related hearing loss, the variant often passes from one generation to the next.
What does my ACTG1 result mean for my family?
ACTG1-related conditions are usually passed down in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same gene change. If a parent carries it, each child has a 1 in 2, or 50%, chance of inheriting it. Some ACTG1 changes happen for the first time in one family member, especially in conditions that affect development, so the result does not always come from a parent.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ACTG1 gene, ACTG1 genetic testing uses a blood or saliva sample and reads the gene’s DNA code in a lab. Results may identify a pathogenic variant, a benign variant, or a variant of uncertain significance, which means the effect on health is not yet clear.
When should I consider getting a genetic test?
Consider ACTG1 testing if hearing loss runs in your family, especially when it starts early or slowly gets worse over time. It may also help explain a child’s developmental delays or other birth differences when a doctor suspects a rare genetic condition linked to ACTG1.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal depends on the condition and on the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more quickly, while others process it more slowly or are more sensitive to its effects. This helps explain why the same medication may work well for one person but less well for another, or why side effects can differ. These differences are common and are one part of how treatment response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ACTG1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication use, so questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
ACTG1 entered medical genetics through studies of inherited hearing loss in the late 1990s, when researchers linked variants in this gene to DFNA20/26, a form of hearing loss that can run in families. Inheritance patterns were noticed long before the gene was identified. Building on this early work, scientists uncovered more about the ACTG1 gene by connecting other variants to a broader range of features, including a rare developmental condition now called Baraitser Winter syndrome. These findings showed that the same gene could be involved in quite different clinical pictures. Over time, descriptions became more precise. Today, ACTG1 is mainly recognized through this steady progress in hearing and developmental genetics rather than through a single public event or widely known media story.